Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07285798 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorTrial sites expanded: 63 → 67 locationsStart date: Sep 11, 2026 to Oct 2, 2026 · Eligibility criteria expanded, about 7 words · Secondary endpoints: details revised at 1 of 13 entriesShow 3 more changesShow less
Start date: Sep 11, 2026 to Oct 2, 2026
Eligibility criteria expanded, about 7 words
Secondary endpoints: details revised at 1 of 13 entries
MinorTrial sites expanded: 54 → 63 locationsPrimary and study completion dates: Aug 4, 2029 to Aug 6, 2029v6Show 1 more changeShow less
Primary and study completion dates: Aug 4, 2029 to Aug 6, 2029
MinorStudy sites: 55 to 54Secondary endpoints: details revised at 5 of 13 entries · Eligibility criteria shortened, about 2 wordsv5Show 2 more changesShow less
Secondary endpoints: details revised at 5 of 13 entries
NotableStart date: Feb 27, 2026 to Sep 11, 2026Study sites: 54 to 55v4Show 1 more changeShow less
Study sites: 54 to 55
MinorStudy sites: 53 to 54v3
MinorStudy sites: 51 to 53v2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.